Who Exports Ivermectin from India — 352 Suppliers Behind a $8.7M Market
India's ivermectin export market is supplied by 352 active exporters who collectively shipped $8.7M across 11,765 shipments. SAVA HEALTHCARE LIMITED leads with a 27.0% market share, followed by ZYDUS LIFESCIENCES LIMITED and ANTILA LIFESCIENCES PRIVATE LIMITED. The top 5 suppliers together control 49.7% of total export value, reflecting a moderately competitive market structure.
Top Ivermectin Exporters from India — Ranked by Export Value
SAVA HEALTHCARE LIMITED is the leading ivermectin exporter from India, holding a 27.0% share of the $8.7M market across 11,765 shipments from 352 exporters. The top 5 suppliers — SAVA HEALTHCARE LIMITED, ZYDUS LIFESCIENCES LIMITED, ANTILA LIFESCIENCES PRIVATE LIMITED, RUBICON RESEARCH LIMITED, BULL PHARMACHEM — collectively control 49.7% of total export value, indicating a competitive market. Individual shares are: SAVA HEALTHCARE LIMITED (27.0%), ZYDUS LIFESCIENCES LIMITED (6.9%), ANTILA LIFESCIENCES PRIVATE LIMITED (5.9%), RUBICON RESEARCH LIMITED (5.2%), BULL PHARMACHEM (4.7%).
Top Ivermectin Exporters from India
Ranked by export value · 352 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SAVA HEALTHCARE LIMITED IVERMECTOL 12MG 48TAB IVERMECTINNEW IVERMECTOL 12MG 48 TAB IVERMECTINIVERMECTOL 12MG 48TAB IVERMECTINNOS | $2.3M | 2 | 27.0% |
| 2 | ZYDUS LIFESCIENCES LIMITED PHARMA : IVERMECTIN CREAM 1% (IVERMECTINIVERMECTIN CREAM 1% 45 GM 1X45GMPHARMA : IVERMECTIN CREAM 1% - 1X45GM | $596.5K | 2 | 6.9% |
| 3 | ANTILA LIFESCIENCES PRIVATE LIMITED IVERMAX INJ -50ML ( IVERMECTIN+CLORSULONIVERMAX INJ -50MLIVERMECTIN INJECTION B.P. 1% W/V | $511.4K | 1 | 5.9% |
| 4 | RUBICON RESEARCH LIMITED PHARMA : IVERMECTIN CREAM 1% (IVERMECTINIVERMECTIN CREAM 1% 45 GM 1X45GMPHARMA : IVERMECTIN CREAM 1% - 1X45GM | $453.2K | 1 | 5.2% |
| 5 | BULL PHARMACHEM IVERHEAL 12 IVERMECTIN 12MGHVTEK PLUS IVERMECTIN 12MGIVERHEAL 12 - IVERMECTIN 12MG - | $412.0K | 1 | 4.7% |
| 6 | MEDINOMICS HEALTH CARE PRIVATE LIMITED IVERMAX INJ -50ML ( IVERMECTIN+CLORSULONIVERMAX INJ -50MLIVERMECTIN INJECTION B.P. 1% W/V | $314.9K | 1 | 3.6% |
| 7 | SELLWELL PHARMACEUTICALS LIMITED INJ. IVERMECTIN 1% 50ML OTHEINJ.IVERMECTIN 1% 100ML OTHERINJ. IVERMECTIN 1% 10ML OTHE | $310.9K | 1 | 3.6% |
| 8 | YELURI FORMULATIONS PRIVATE LIMITED KC-IVER (IVERMECTIN INJECTION 1KC-IVER (IVERMECTIN INJECTION 1%KC-IVER 50ML (IVERMECTIN INJECTION 1%W/V | $234.3K | 1 | 2.7% |
| 9 | DERRIC WOOD PHARMACEUTICALS PRODUCTS IVERVID 12 MGIVERMECTIN1X10PHARMACEUTICALS PRODUCTS IVERVID 12 MGIVERMECTIN1X10NOSAUSTRO IVERMECTIN 12MG SIZE | $229.2K | 2 | 2.6% |
| 10 | HEXA HEALTH CARE PRIVATE LIMITED IVERMECTOL 12MG 48TAB IVERMECTINNEW IVERMECTOL 12MG 48 TAB IVERMECTINIVERMECTOL 12MG 48TAB IVERMECTINNOS | $201.5K | 1 | 2.3% |
| 11 | CADILA HEALTHCARE LIMITED PHARMA : IVERMECTIN CREAM 1% (IVERMECTINIVERMECTIN CREAM 1% 45 GM 1X45GMPHARMA : IVERMECTIN CREAM 1% - 1X45GM | $185.9K | 1 | 2.1% |
| 12 | ASHISH LIFE SCIENCE PRIVATE LIMITED IVERHEAL 12 IVERMECTIN 12MGIVERMAX INJ -50ML ( IVERMECTIN+CLORSULONHVTEK PLUS IVERMECTIN 12MG | $138.4K | 9 | 1.6% |
| 13 | AGIO PHARMACEUTICALS LIMITED IVERMEC 100 ML 24000 BOTTEL - 100 ML. PER BOTTEL -IVERMEC 100 ML 20000 BOTTEL-EGLOMECTIN INJECTION 100ML IVERMECTIN IN | $138.0K | 5 | 1.6% |
| 14 | GANPATI EXIM INC H.I. MEDICINES & PHARMACEUTICAL PRODUCTSIVERMECTINPRO NOSPHARMACEUTICAL PRODUCT : PACKOF 48 TAB IVERMECTIN 12MGPHARMACEUTICAL PRODUCT MEDICINE PACKOF 1 IVERMECTIN CREAM | $131.2K | 1 | 1.5% |
| 15 | NORTHERN LIFELINE IVERMECTOL 12MG 48TAB IVERMECTINNEW IVERMECTOL 12MG 48 TAB IVERMECTINIVERMECTOL 12MG 48TAB IVERMECTINNOS | $128.3K | 2 | 1.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Ivermectin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| SAVA HEALTHCARE LIMITED | Not Listed | Yes, as of 2025 | Not Listed | Not verified | WHO-GMP certified facility as of 2025. |
| ZYDUS LIFESCIENCES LIMITED | Warning Letter, August 20 | Yes, as of May 2022 | Not Listed | Not verified | Received FDA Warning Letter in August 2024; compliance issues addressed by Decem |
| RUBICON RESEARCH LIMITED | Approved | Not Listed | Not Listed | 2 | Received FDA approval for Valsartan Oral Solution and Topiramate Capsules in 202 |
| YELURI FORMULATIONS PRIVATE LIMITED | Not Listed | Yes | Not Listed | Not verified | WHO-GMP certified manufacturer. |
| CADILA HEALTHCARE LIMITED | Not Listed | Yes, as of May 2022 | Not Listed | Not verified | WHO-GMP certified facility as of May 2022. |
TransData Nexus reviewed the regulatory standing of 5 leading Ivermectin exporters from India. 1 hold US FDA facility approvals, 4 maintain WHO-GMP certification, and 0 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Ivermectin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of active pharmaceutical ingredients (APIs). The city's infrastructure supports large-scale API manufacturing, making it a pivotal hub for raw material supply in the pharmaceutical sector. While specific data on Ivermectin API production in Hyderabad is not readily available, the city's capacity suggests a significant role in supplying APIs for formulations produced elsewhere.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a prominent center for pharmaceutical formulations. Notably, SAVA Healthcare Limited operates a WHO-GMP and PIC/S approved manufacturing plant in Surendranagar, near Ahmedabad. This facility produces a wide range of dosage forms, including tablets, capsules, and nasal sprays, supported by an in-house R&D center. The plant's strategic location and advanced capabilities position it as a key player in the production of Ivermectin formulations for both domestic and international markets.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad region serves as a critical export gateway for India's pharmaceutical products. Mumbai's well-established port facilities and logistical infrastructure facilitate the efficient export of pharmaceuticals, including Ivermectin, to global markets. Companies in this region benefit from proximity to international shipping routes, enhancing their export capabilities.
4Baddi-Nalagarh — Tax Incentive Zone
The Baddi-Nalagarh region in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, largely due to favorable tax incentives. This area attracts numerous pharmaceutical companies seeking cost-effective production solutions. While specific data on Ivermectin production in this cluster is limited, the region's overall manufacturing capacity contributes to the broader pharmaceutical supply chain.
5Sourcing Recommendations
- Evaluate Supplier Capabilities: Assess the manufacturing facilities and quality certifications of potential suppliers, such as SAVA Healthcare Limited, to ensure they meet international standards.
- Consider Geographical Proximity: Select suppliers located in clusters with robust export infrastructure, like the Mumbai-Thane-Raigad region, to streamline logistics and reduce lead times.
- Assess API Sources: Investigate the origin of APIs used in Ivermectin formulations, focusing on clusters like Hyderabad known for API production, to ensure a stable and reliable supply chain.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to regulatory requirements set by authorities such as the Central Drugs Standard Control Organisation (CDSCO) and the Directorate General of Foreign Trade (DGFT) to maintain compliance and product quality.
By strategically analyzing India's pharmaceutical clusters and considering these recommendations, TransData Nexus can optimize its sourcing strategies for Ivermectin, ensuring quality and efficiency in the supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Ivermectin exporters from India
Zydus Lifesciences Limited — Zydus Lifesciences acquires Amplitude Surgical to enter medical devices market
In April 2025, Zydus Lifesciences announced the incorporation of a wholly owned subsidiary, Zydus MedTech (France) SAS, in France, through which it intends to acquire the equity shares of Amplitude Surgical SA. - IMPACT: This acquisition diversifies Zydus's portfolio into medical devices, potentially affecting resource allocation for Ivermectin production.
Impact: This acquisition diversifies Zydus's portfolio into medical devices, potentially affecting resource allocation for Ivermectin production.
Rubicon Research Limited — Rubicon Research acquires Pithampur manufacturing facility from Alkem Laboratories
In January 2025, Rubicon Research Limited acquired Alkem Laboratories Limited's manufacturing facility in Pithampur, Madhya Pradesh, for INR 1,490 million on a slump sale basis. - IMPACT: The acquisition enhances Rubicon's manufacturing capacity, potentially increasing Ivermectin production capabilities.
Impact: The acquisition enhances Rubicon's manufacturing capacity, potentially increasing Ivermectin production capabilities.
Zydus Lifesciences Limited — Zydus Lifesciences acquires 85.6% stake in Amplitude Surgical
In February 2024, Zydus Lifesciences acquired an 85.6% stake in France-based Amplitude Surgical for €256.8 million, marking its entry into the medical devices segment. - IMPACT: This strategic move into medical devices may influence Zydus's focus and investment in pharmaceutical products like Ivermectin.
Impact: This strategic move into medical devices may influence Zydus's focus and investment in pharmaceutical products like Ivermectin.
Common Questions — Ivermectin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which ivermectin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SAVA HEALTHCARE LIMITED leads with 346 recorded shipments worth $2.3M. ZYDUS LIFESCIENCES LIMITED (24 shipments) and ANTILA LIFESCIENCES PRIVATE LIMITED (22 shipments) are also established high-volume exporters.
Q How many ivermectin manufacturers are there in India?
India has 352 active ivermectin exporters with a combined export market of $8.7M across 11,765 shipments to 140 countries. The top 5 suppliers hold 49.7% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for ivermectin from India?
Average FOB unit price: $2.31 per unit, ranging from $0.00 to $1080.56. Average shipment value: $738.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 352 verified Indian exporters of Ivermectin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 11,765 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 140 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11,765 Verified Shipments
352 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists